이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
Hims & Hers Health 관리
관리 기준 확인 1/4
Hims & Hers Health's CEO는 Andrew Dudum, Jan2017 에 임명되었습니다 의 임기는 7.42 년입니다. 총 연간 보상은 $ 14.40M, 4.2% 로 구성됩니다. 4.2% 급여 및 95.8% 보너스(회사 주식 및 옵션 포함). 는 $ 482.78M 가치에 해당하는 회사 주식의 9.07% 직접 소유합니다. 482.78M. 경영진과 이사회의 평균 재임 기간은 각각 2.3 년과 2.5 년입니다.
주요 정보
Andrew Dudum
최고 경영자
US$14.4m
총 보상
| CEO 급여 비율 | 4.2% |
| CEO 임기 | 7.4yrs |
| CEO 소유권 | 9.1% |
| 경영진 평균 재임 기간 | 2.3yrs |
| 이사회 평균 재임 기간 | 2.5yrs |
최근 관리 업데이트
Recent updates
Why Investors Shouldn't Be Surprised By Hims & Hers Health, Inc.'s (NYSE:HIMS) 70% Share Price Surge
Jun 19
Hims & Hers: The Undervalued Gem Poised For Growth
Jun 18Beyond The Marketing Machine: Why Hims & Hers Stock Might Be Vulnerable
Jun 10Hims & Hers Health, Inc.'s (NYSE:HIMS) CEO Compensation Is Looking A Bit Stretched At The Moment
May 31Hims & Hers: Soaring On Access To Compounded GLP-1 Drugs, Further Volatility Ahead
May 21Hims & Hers Health: An Unforced Error
May 06Hims & Hers Health, Inc. (NYSE:HIMS) Stocks Pounded By 27% But Not Lagging Industry On Growth Or Pricing
May 04Hims & Hers Health: Becoming A Market Leader Within The Growing Digital Health Industry
Apr 24Hims & Hers Health: Strong Prospects But Weak Business Model Consolidation
Apr 05Hims & Hers: 5 Reasons Why This Is A Phenomenal Long-Term Growth Stock
Mar 21Pills Pay The Bills: Mini Deep Dive On Hims & Hers Health
Mar 12Investors Appear Satisfied With Hims & Hers Health, Inc.'s (NYSE:HIMS) Prospects As Shares Rocket 49%
Feb 28Hims & Hers: Turning The Profitability Corner And Returning 28%
Feb 25Hims & Hers Health: No Clear Moat Besides First Mover Advantage
Jan 23Hims & Hers Health: Unleashing Macro Momentum - Investing In Growth At A Higher Multiple
Jan 10Investors Still Waiting For A Pull Back In Hims & Hers Health, Inc. (NYSE:HIMS)
Jan 07Hims & Hers Health Q3: The Cheapest Growth Stock Around
Dec 14Hims & Hers Health: What Would The Author Of 100 Baggers Say?
Nov 30Hims & Hers: The Most Undervalued Small Cap Stock I See
Nov 08Hims & Hers: A Promising Company With Resolvable Challenges
Nov 02Hims & Hers: Specialization Is The Secret To Great Growth
Oct 25Hims & Hers Health: Can't Get Much Better
Sep 25The Market Is Wrong On Hims & Hers Health
Sep 18Hims & Hers: The Current Weakness Creates A Buying Opportunity
Aug 15Hims & Hers Health: Giving Investors Another Bite At The Apple
Aug 01Hims & Hers Health, Inc.'s (NYSE:HIMS) Price In Tune With Revenues
Jul 21Hims & Hers Health: Expect Strong EBITDA Growth As Revenue Growth Remains Strong
Jul 13Hims & Hers Health: Double-Edged Sword
Jul 02Hims & Hers: More Transparency Could Help The Stock
Jun 09Hims & Hers Health (NYSE:HIMS) Is In A Strong Position To Grow Its Business
Apr 19Are Investors Undervaluing Hims & Hers Health, Inc. (NYSE:HIMS) By 41%?
Mar 30Him & Hers Health Q4 2022 Earnings Preview
Feb 24Hims & Hers spikes as Jefferies upgrades ahead of 2023 guidance
Feb 09CEO 보상 분석
| 날짜 | 총 보상 | 급여 | 회사 수익 |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | -US$2m |
| Dec 31 2023 | US$14m | US$612k | -US$24m |
| Sep 30 2023 | n/a | n/a | -US$36m |
| Jun 30 2023 | n/a | n/a | -US$47m |
| Mar 31 2023 | n/a | n/a | -US$59m |
| Dec 31 2022 | US$11m | US$600k | -US$66m |
| Sep 30 2022 | n/a | n/a | -US$86m |
| Jun 30 2022 | n/a | n/a | -US$83m |
| Mar 31 2022 | n/a | n/a | -US$73m |
| Dec 31 2021 | US$15m | US$574k | -US$108m |
| Sep 30 2021 | n/a | n/a | -US$82m |
| Jun 30 2021 | n/a | n/a | -US$72m |
| Mar 31 2021 | n/a | n/a | -US$63m |
| Dec 31 2020 | US$27m | US$527k | -US$18m |
| Sep 30 2020 | n/a | n/a | -US$25m |
| Jun 30 2020 | n/a | n/a | -US$38m |
| Mar 31 2020 | n/a | n/a | -US$58m |
| Dec 31 2019 | US$254k | US$254k | -US$72m |
보상 대 시장: Andrew 의 총 보상 ($USD 14.40M )은 US 시장( $USD 8.45M ).
보상과 수익: 회사가 수익성이 없는 동안 Andrew 의 보상이 증가했습니다.
CEO
Andrew Dudum (35 yo)
7.4yrs
테뉴어
US$14,401,411
보상
Mr. Andrew Dudum serves as Chairman of the Board and serves as Chief Executive Officer at Hims & Hers Health, Inc. since January 20, 2021. He Co-Founded Hims & Hers Health, Inc. in 2017. He is Co-founded H...
리더십 팀
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| Co-Founder | 7.4yrs | US$14.40m | 9.1% $ 437.8m | |
| Chief Financial Officer | 2.4yrs | US$7.43m | 0.088% $ 4.2m | |
| Chief Operating Officer | 3.4yrs | US$6.77m | 0.27% $ 13.1m | |
| Chief Legal Officer & Corporate Secretary | 3.4yrs | US$5.21m | 0.081% $ 3.9m | |
| Chief Medical Officer | 1.5yrs | US$198.26k | 0.094% $ 4.5m | |
| Chief Commercial Officer | less than a year | US$6.71m | 0.086% $ 4.1m | |
| Senior VP | 5yrs | US$961.12k | 0.0014% $ 65.4k | |
| Chief Communications Officer | less than a year | 데이터 없음 | 데이터 없음 | |
| Senior Vice President of Human Resources | 2.3yrs | 데이터 없음 | 데이터 없음 | |
| Senior VP & Member of Medical Advisory Board | no data | 데이터 없음 | 데이터 없음 | |
| Chief Pharmacy & Innovation Officer | 1.5yrs | 데이터 없음 | 데이터 없음 | |
| Senior Vice President of Mental Health | 1.3yrs | 데이터 없음 | 데이터 없음 |
2.3yrs
평균 재임 기간
44yo
평균 연령
경험이 풍부한 관리: HIMS 의 관리팀은 경험 ( 2.3 년 평균 재직 기간)으로 간주됩니다.
이사회 구성원
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| Co-Founder | 3.4yrs | US$14.40m | 9.1% $ 437.8m | |
| Chief Medical Officer | 2.3yrs | US$198.26k | 0.094% $ 4.5m | |
| Senior VP & Member of Medical Advisory Board | 2.4yrs | 데이터 없음 | 데이터 없음 | |
| Independent Director | 3.8yrs | US$194.26k | 0.025% $ 1.2m | |
| Lead Independent Director | 3.8yrs | US$227.41k | 0.087% $ 4.2m | |
| Independent Director | 3.3yrs | US$205.51k | 0.034% $ 1.6m | |
| Member of Medical Advisory Board | 2.5yrs | 데이터 없음 | 데이터 없음 | |
| Member of Medical Advisory Board | no data | 데이터 없음 | 데이터 없음 | |
| Member of Medical Advisory Board | 2.5yrs | 데이터 없음 | 데이터 없음 | |
| Member of Medical Advisory Board | 2.5yrs | 데이터 없음 | 데이터 없음 | |
| Member of Medical Advisory Board | 2.5yrs | 데이터 없음 | 데이터 없음 | |
| Member of Medical Advisory Board | 2.5yrs | 데이터 없음 | 데이터 없음 |
2.5yrs
평균 재임 기간
53yo
평균 연령
경험이 풍부한 이사회: HIMS 의 이사회는 경험(평균 재직 기간 2.5 년)으로 간주되지 않으므로 새 이사회가 필요합니다.